Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: A twenty-four-week, single-blind, randomized study

Arthritis and Rheumatism

Volumn 42, Issue 10, 1999, Pages 2160-2165

  Luis, Magdalena ^a   Pacheco Tena, César ^b   Cazarín Barrientos, Jorge ^a   Lino Pérez, Leticia ^a   Goycochea, María Victoria ^a   Vázquez Mellado, Janitzia ^a   Burgos Vargas, Rubén ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHLOROQUINE; METHOTREXATE; PREDNISONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; METHOTREXATE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0033496274     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199910)42:10<2160::AID-ANR17>3.0.CO;2-T     Document Type: Article

References (19)

1. O'Dell JR. Methotrexate use in rheumatoid arthritis. Rheum Dis Clin North Am 1998;23:779-96.
2. Weinblatt M, Maier A, Fraser P, Coblyn J. Long-term prospective study of methotrexate in rheumatoid arthritis: conclusions after 132 months of therapy. J Rheumatol 1998;25:238-42.
3. Weinstein GD, Frost P. Methotrexate for psoriasis: a new therapeutic schedule. Arch Dermatol 1971;103:33-6.
4. Dahl MGC, Gregory MM, Scheuer PJ. Methotrexate hepatotoxicity in psoriasis - comparison of different dose regimes. BMJ 1972;1:654-6.
5. Millward-Sadler GH, Ryan TJ. Methotrexate induced liver disease in psoriasis. Br J Dermatol 1974;90:661-7.
6. Hall PD, Jenner MA, Ahern MJ. Hepatotoxicity in a rat model caused by orally administered methotrexate. Hepatology 1991;14: 906-12.
7. Tishler M, Caspi D, Yaron M. Methotrexate treatment of rheumatoid arthritis: is a fortnightly maintenance schedule enough? Ann Rheum Dis 1992;51:1330-1.
8. Kremer JH, Davies JMS, Rynes RI, Fink S, Lawrence DA, Petrillo GF, et al. Every-other-week methotrexate in patients with rheumatoid arthritis: a double-blind, placebo-controlled prospective study. Arthritis Rheum 1995;38:601-7.
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Pinals RS, Masi AT, Larsen RA, and the Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.
11. Cardiel MH, Abello-Banfi M, Ruiz-Mercado R, Alarcón-Segovia D. How to measure health status in rheumatoid arthritis in non-English speaking patient: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI). Clin Exp Rheumatol 1993;11:117-21.
12. Matthews JNS, Altman DG. Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
13. Kremer TM, Rynes RI, Bartolomeo LE. Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Am J Med 1987;82:781-6.
14. Cimaz R, Corona F, Scarazatto M, Cohen E, Bardare M. Methotrexate treatment every other week in patients with juvenile chronic arthritis. Br J Rheumatol 1996;35:1030-1.
15. Bleyer WA. The clinical pharmacology of methotrexate: new applications of an old drug. Cancer 1978;41:36-51.
16. Jolivet J, Cowan KH, Curt GA. The pharmacology and clinical use of methotrexate. N Engl J Med 1983;309:1094-104.
17. Wolfe F, Hawley DJ. Remission in rheumatoid arthritis. J Rheumatol 1985;12:245-52.
18. Mazieres B, Arlet J, Thelmann MD, Vidal R, Bismuth M. Remission in rheumatoid arthritis: apropos of 32 case reports. Rhev Rhum 1985;52:445-50.
19. Pillemer SR, Fowler SE, Tilley BC, Alarcón GS, Heyse SP, Trentham DE, et al, for the MIRA Trial Group. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. Arthritis Rheum 1997;40:419-25.